Am J Transplant, Volume 16, Suppl 3 Archives - Page 11 of 180 - ATC Abstracts

2016 American Transplant Congress
Pre-Transplant Anti-A Titers in Waitlisted A2 to B Kidney Transplant Candidates.
D. Moore, I. Feurer, R. Forbes, A. DeMers, D. Shaffer.
Vanderbilt University, Nashville, TN.
Introduction:The KAS allocates A2 and A2B donor kidneys to blood type B candidates. Research is limited and variability exists among centers regarding the significance, relevance,…
2016 American Transplant Congress
Reducing Non-Anastomotic Biliary Strictures After Donation After Circulatory Death Liver Transplantation, a Matter of Time?
N. Gilbo, I. Jochmans, M. Sainz, J. Pirenne, D. Monbaliu.
Abdominal Transplantation Surgery, KU Leuven, Leuven, Belgium.
Liver Transplantation (LT) from donation after circulatory death (DCD) is associated with increased non-anastomotic biliary strictures (NAS) and graft loss. Donor and recipient demographics, transplant…
2016 American Transplant Congress
Outcomes of Anticoagulation Use for Portal Vein Thrombosis in University of Wisconsin Liver Transplant Patients.
M. Falls,¹ A. Said,² L. Fernandez,² D. Foley,² K. Frith,¹ D. Hager,² H. Hoy,¹ G. Leverson,² J. Mezrich,² T. Prickette,² M. Wakefield,² A. D'Alessandro.²
¹School of Nursing, University of Alabama, Huntsville, AL; ²Transplant Surgery, University of Wisconsin, Madison, WI.
Background: The prevalence of Portal Vein Thrombosis (PVT) in cirrhotic liver transplant patients increases the risk of morbidity and mortality post-liver transplantation. Current research suggests…
2016 American Transplant Congress
Anterior Rectus Sheath Approach for Renal Transplant: An Open Minimal Incision with Decreased Wound Complications.
S. Phillips,¹ S. Hill,¹ L. Lipscomb,¹ B. Sankari,² S.-C. Chueh,² J. Africa.²
¹Charleston Area Medical Center, Charleston, WV; ²Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.
Preventing wound complications is an important goal in all surgery. The reduction of modifiable risk factors, like surgical approach, is an important step towards protecting…
2016 American Transplant Congress
Resource Utilization and Cost Analysis of Early Hospital Readmissions Following Kidney Transplantation.
M. Au, O. Famure, Y. Li, J. Kim.
Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
Background: Early hospital readmissions (EHRs) following kidney transplant are associated with poor transplant outcomes and a greater burden on the healthcare system. However, the financial…
2016 American Transplant Congress
Initial Evaluation of Use of NAT in Assignment of CMV and EBV Infection Status in Children Awaiting Solid Organ Transplant.
C. Burton, Y. Tong, J. Preiksaitis.
Medicine, University of Alberta, Edmonton, Canada.
Purpose: The presence of passive antibodies, transfusion-acquired or maternal in infants, can make serologic determination of pre-transplant CMV and EBV status in children unreliable. We…
2016 American Transplant Congress
Influence of Country-Associated Geographical Variables in the Ouctomes of Kidney Transplantation in Patients with HIV-Infection.
M. Cristelli,¹ F. Cofán,² H. Tedesco-Silva,¹ J. Trullas,³ D. Santos,¹ C. Manzardo,⁴ F. Aguero,⁴ A. Moreno,⁴ F. Oppenheimer,² F. Dieckmann,¹ J. Miro,⁴ J. Medina-Pestana.¹
¹Hospital do Rim-UNIFESP, São Paulo, Brazil; ²Nephrology, Hospital Clinic-IDIBAPS, Barcelona, Spain; ³Hospital de Olot, Girona, Spain; ⁴Infectology, Hospital Clinic-IDIBAPS, Barcelona, Spain.
Objective: To evaluate effects of geographical factors on demography, clinical management and evolution of two cohorts of HIV-infected KT recipients.Methods: Observational, retrospective cohort study including…
2016 American Transplant Congress
The Phenotypic Diversity of Late Silent Antibody-Mediated Rejection.
F. Eskandary,^1,2 J. Reeve,^1,3 H. Regele,⁴ L. Hidalgo,^1,3 D. Yoo,¹ N. Kozakowski,⁴ K. Famulski,¹ G. Böhmig,² P. Halloran.^1,5
¹Alberta Transplant Applied Genomics Centre, University of Alberta, Edmonton, AB, Canada; ²Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria; ³Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada; ⁴Department of Clinical Pathology, Medical University of Vienna, Vienna, Austria; ⁵Department of Medicine, Division of Nephrology and Transplant Immunology, University of Alberta, Edmonton, AB, Canada.
Study purpose: ABMR is a driving force of long-term allograft loss in organ transplantation. The present study was designed to characterize the phenotypic diversity of…
2016 American Transplant Congress
Diffuse Extent of Peritubular Capillaritis in Late Antibody Mediated Rejection Is Associated with More Severe Chronic Allograft Damage.
Z. Kikić,¹ F. Eskandary,¹ H. Herkner,² R. Oberbauer,¹ G. Bond,¹ H. Regele,³ G. Böhmig,¹ N. Kozakowski.³
¹Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria; ²Emergency Medicine, Medical University of Vienna, Vienna, Austria; ³Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria.
Peritubular capillaritis (ptc) is a widely accepted histologic criterion of antibody-mediated rejection (ABMR), and while the ptc score is incorporated in current diagnostic recommendations, the…
2016 American Transplant Congress
iNKT Cell Ligands Administered with Bone Marrow Cells Expand Allo-Specific Regulatory T Cells In Vivo and Establish Transplant Tolerance.
S. Miyairi,^1,2 T. Hirai,¹ M. Okumi,¹ Y. Ishii,³ K. Yamazaki,² K. Tanabe.¹
¹Urology, Tokyo Women's Medical University, Tokyo, Japan; ²Cardiovascular Surgery, Tokyo Women's Medical University, Tokyo, Japan; ³Vaccine Design, RIKEN IMS-RCAI, Yokohama, Japan.
Invariant natural killer T(iNKT) cells have the powerful potential to expand regulatory T cells(Tregs), especially when they are presented α-galactosylceramide(aGC) by B cells. We previously…